Steward Partners Investment Advisory, LLC Altimmune, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 28,050 shares of ALT stock, worth $185,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,050
Previous 20,200
38.86%
Holding current value
$185,410
Previous $124,000
62.9%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALT
# of Institutions
191Shares Held
38.1MCall Options Held
869KPut Options Held
743K-
Black Rock Inc. New York, NY5.32MShares$35.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$29.3 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.88MShares$25.6 Million0.01% of portfolio
-
State Street Corp Boston, MA3.41MShares$22.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$18.2 Million1.44% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $324M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...